Cargando…

Clostridioides difficile infections in Saudi Arabia: Where are we standing?

Clostridioides difficile infections (CDIs) are infamous healthcare-associated infections for causing watery diarrhea to long-term hospitalized patients with a high mortality rate. Epidemiological reports from western countries showed up-trending pattern in the number of CDIs cases. It is becoming im...

Descripción completa

Detalles Bibliográficos
Autores principales:	Obaid, Najla A., Alhifany, Abdullah A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7474162/ https://www.ncbi.nlm.nih.gov/pubmed/32922143 http://dx.doi.org/10.1016/j.jsps.2020.07.013

Ejemplares similares

Home infusion services in Saudi Arabia: Where are we standing?
por: Alhifany, Abdullah A., et al.
Publicado: (2023)

Patient–ventilator asynchrony in Saudi Arabia: Where we stand?
por: Alqahtani, Jaber S
Publicado: (2021)

The prevalence of chronic obstructive pulmonary disease in Saudi Arabia: Where do we stand?
por: Al Ghobain, Mohammed
Publicado: (2011)

Vaccination Against Invasive Pneumococcal Disease in Saudi Arabia: Where Do We Stand?
por: Frayha, Husn H., et al.
Publicado: (2005)

Epilepsy monitoring units in Saudi Arabia:: Where do we stand compared to developed countries?
por: Aljafen, Bandar N., et al.
Publicado: (2018)

Where are we today with Helicobacter pylori infection among healthy children in Saudi Arabia?
por: Al-Hussaini, Abdulrahman A., et al.
Publicado: (2019)

Vancomycin vs metronidazole use for the treatment of Clostridioides difficile infection in a tertiary care hospital in Saudi Arabia
por: Alhameed, Abrar F., et al.
Publicado: (2023)

Alzheimer’s disease and infections, where we stand and where we go
por: Monastero, Roberto, et al.
Publicado: (2014)

Preventive Measures and Management of Catheter-Associated Urinary Tract Infection in Adult Intensive Care Units in Saudi Arabia
por: Obaid, Najla A.
Publicado: (2021)

Public knowledge, perception, and experience with generic medications in Saudi Arabia
por: Almohammed, Omar A., et al.
Publicado: (2020)

2572. Adherence to Evidence-based Guidelines for the Management of Pneumonia in a Tertiary Teaching Hospital in Saudi Arabia
por: Alhifany, Abdullah A
Publicado: (2023)

Frailty in Kingdom of Saudi Arabia—Prevalence and Management, Where Are We? †
por: Alshanberi, Asim Muhammed
Publicado: (2023)

Diagnostic Methods of Clostridioides difficile Infection and Clostridioides difficile Ribotypes in Studied Sample
por: Novakova, Elena, et al.
Publicado: (2021)

Where Do We Stand?
Publicado: (1891)

Extraintestinal Clostridioides difficile infection
por: Hai, Zhao, et al.
Publicado: (2020)

Cancer: Where We Stand
Publicado: (1951)

Dental publications at the Saudi Medical Journal: Where do we stand 2009-2016
por: Al-Mohaya, Maha A.
Publicado: (2016)

Overweight and obesity among Saudi children and adolescents: Where do we stand today?
por: Al-Hussaini, Abdulrahman, et al.
Publicado: (2019)

Addictive behaviors: where do we stand, and where are we going?
por: Thibaut, Florence, et al.
Publicado: (2017)

Joint Discussion – Where we stand and where we want to go
por: CERN. Geneva
Publicado: (2013)

Joint Discussion – Where we stand and where we want to go
por: CERN. Geneva
Publicado: (2013)

Neutrino Masses and Mixing: Where We Stand and Where We are Going
por: Gonzalez-Garcia, M.C.
Publicado: (2002)

Corneal xenotransplantation: Where are we standing?
por: Yoon, Chang Ho, et al.
Publicado: (2021)

Recurrent Glioblastoma: Where we stand
por: Roy, Sanjoy, et al.
Publicado: (2015)

Barrett's Esophagus: Where Do We Stand?
por: Al Madi, Majid A.
Publicado: (2009)

Telemedicine in India: Where do we stand?
por: Chellaiyan, Vinoth G., et al.
Publicado: (2019)

THREE-DIMENSIONAL PRINTING IN ORTHOPEDICS: WHERE WE STAND AND WHERE WE ARE HEADING
por: EJNISMAN, LEANDRO, et al.
Publicado: (2021)

Gravity: where do we stand ?
por: Peron, Roberto, et al.
Publicado: (2016)

Where we stand with the real superworld
por: Zichichi, Antonino
Publicado: (1993)

Correcting LEP: where we stand
por: Kleiss, R H
Publicado: (1989)

Genetics of Keratoconus: Where Do We Stand?
por: Abu-Amero, Khaled K., et al.
Publicado: (2014)

Clostridioides (Clostridium) difficile Pacemaker Infection
por: Berkefeld, Anna, et al.
Publicado: (2020)

Opportunities for Nanomedicine in Clostridioides difficile Infection
por: Wang, Pei-Wen, et al.
Publicado: (2021)

Phage therapy for Clostridioides difficile infection
por: Fujimoto, Kosuke, et al.
Publicado: (2022)

Novel and emerging sources of Clostridioides difficile infection
por: Turner, Nicholas A., et al.
Publicado: (2019)

Clostridioides difficile infection in the Asia-Pacific region
por: Collins, Deirdre A., et al.
Publicado: (2019)

Biomarkers for Alzheimer’s Disease: Where Do We Stand and Where Are We Going?
por: Villa, Chiara
Publicado: (2020)

Sympathetic Modulation in Cardiac Arrhythmias: Where We Stand and Where We Go
por: Chung, Wei-Hsin, et al.
Publicado: (2023)

Prevalence of post-traumatic stress disorder during the COVID-19 pandemic in Saudi Arabia
por: Alshehri, Fahad S., et al.
Publicado: (2020)

Genomic characterization of nine Clostridioides difficile strains isolated from Korean patients with Clostridioides difficile infection
por: Ahn, Seung Woo, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_hhum2vc7srrg4ls0prtphp1h96